Triple
T6064037
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Faculty of Medicine Heidelberg |
E135109
|
entity |
| Predicate | affiliatedWith |
P254
|
FINISHED |
| Object |
National Center for Tumor Diseases Heidelberg
The National Center for Tumor Diseases Heidelberg is a leading German comprehensive cancer center that integrates cutting-edge research, interdisciplinary clinical care, and translational oncology to improve cancer diagnosis and treatment.
|
E567169
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: National Center for Tumor Diseases Heidelberg | Statement: [Faculty of Medicine Heidelberg, affiliatedWith, National Center for Tumor Diseases Heidelberg]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: National Center for Tumor Diseases Heidelberg Context triple: [Faculty of Medicine Heidelberg, affiliatedWith, National Center for Tumor Diseases Heidelberg]
-
A.
German Cancer Research Center
The German Cancer Research Center is a leading biomedical research institution in Germany dedicated to understanding cancer and developing new strategies for its prevention, diagnosis, and treatment.
-
B.
Royal Institute for Experimental Therapy, Frankfurt
The Royal Institute for Experimental Therapy in Frankfurt was a pioneering biomedical research institute in Germany, closely associated with Paul Ehrlich’s groundbreaking work in immunology and chemotherapy.
-
C.
Faculty of Medicine Heidelberg
The Faculty of Medicine Heidelberg is the medical school of Heidelberg University, renowned for its research-intensive programs and clinical training in one of Germany’s leading academic medical centers.
-
D.
German Center for Lung Research
The German Center for Lung Research is a national research network in Germany dedicated to advancing the understanding, prevention, and treatment of lung diseases through collaborative, translational research.
-
E.
University Hospital Bonn
University Hospital Bonn is a major academic medical center in Bonn, Germany, providing advanced clinical care, medical research, and teaching in partnership with the University of Bonn.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: National Center for Tumor Diseases Heidelberg Triple: [Faculty of Medicine Heidelberg, affiliatedWith, National Center for Tumor Diseases Heidelberg]
Generated description
The National Center for Tumor Diseases Heidelberg is a leading German comprehensive cancer center that integrates cutting-edge research, interdisciplinary clinical care, and translational oncology to improve cancer diagnosis and treatment.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: National Center for Tumor Diseases Heidelberg Target entity description: The National Center for Tumor Diseases Heidelberg is a leading German comprehensive cancer center that integrates cutting-edge research, interdisciplinary clinical care, and translational oncology to improve cancer diagnosis and treatment.
-
A.
German Cancer Research Center
The German Cancer Research Center is a leading biomedical research institution in Germany dedicated to understanding cancer and developing new strategies for its prevention, diagnosis, and treatment.
-
B.
Royal Institute for Experimental Therapy, Frankfurt
The Royal Institute for Experimental Therapy in Frankfurt was a pioneering biomedical research institute in Germany, closely associated with Paul Ehrlich’s groundbreaking work in immunology and chemotherapy.
-
C.
Faculty of Medicine Heidelberg
The Faculty of Medicine Heidelberg is the medical school of Heidelberg University, renowned for its research-intensive programs and clinical training in one of Germany’s leading academic medical centers.
-
D.
German Center for Lung Research
The German Center for Lung Research is a national research network in Germany dedicated to advancing the understanding, prevention, and treatment of lung diseases through collaborative, translational research.
-
E.
University Hospital Bonn
University Hospital Bonn is a major academic medical center in Bonn, Germany, providing advanced clinical care, medical research, and teaching in partnership with the University of Bonn.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69c00878d06881909ee78e88913bf890 |
completed | March 22, 2026, 3:19 p.m. |
| NER | Named-entity recognition | batch_69c05723c91c819090b4d4672e72f9f3 |
completed | March 22, 2026, 8:54 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69c11d1e61188190aea0e2b1945ca682 |
completed | March 23, 2026, 10:59 a.m. |
| NEDg | Description generation | batch_69c11da387dc819088fc37ea1c3daed8 |
completed | March 23, 2026, 11:01 a.m. |
| NED2 | Entity disambiguation (via description) | batch_69c11e5efd848190adb834e42b4bdc9e |
completed | March 23, 2026, 11:05 a.m. |
Created at: March 22, 2026, 4:10 p.m.